Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Common stock, balance at beginning of period (in shares) at Dec. 31, 2019		208,116,104
Balance at beginning of period at Dec. 31, 2019	$ 121,142	$ 208	$ 459,573	$ (338,611)	$ (28)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,040			13,040
Capital contributions	1,083		1,083
Reclassification of liability awards to equity upon modification	0
Stock-based compensation	1,379		1,379
Compensatory units repurchased	(732)		(732)
Other comprehensive income (loss)	98				98
Common stock, balance at end of period (in shares) at Mar. 31, 2020		208,116,104
Balance at end of period at Mar. 31, 2020	136,010	$ 208	461,303	(325,571)	70
Common stock, balance at beginning of period (in shares) at Dec. 31, 2020		208,116,104
Balance at beginning of period at Dec. 31, 2020	228,925	$ 208	412,741	(184,033)	9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	49,418			49,418
Capital contributions	200		200
Initial public offering, net of offering costs (in shares)		13,250,000
Initial public offering, net of offering costs	242,668	$ 13	242,655
Repurchase upon corporate reorganization (in shares)		(524)
Repurchase upon Corporate Reorganization	(10)		(10)
Reclassification of liability awards to equity upon modification	10,784		10,784
Stock-based compensation	6,635		6,635
Compensatory units repurchased	(160)		(160)
Other comprehensive income (loss)	(13)				(13)
Common stock, balance at end of period (in shares) at Mar. 31, 2021		221,365,580
Balance at end of period at Mar. 31, 2021	$ 538,447	$ 221	$ 672,845	$ (134,615)	$ (4)